Marrone Bio Innovations Inc. logo

Marrone Bio Innovations (MBII) stock

MBII · Marrone Bio Innovations Inc. · NASDAQ

Website

What is the latest news on MBII stock?

PRago
ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions

ROTH MKM ("Roth"), www.roth.com, a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group has advised on three sellside transactions in the past nine months. The transactions included business models in the areas of cover crops, gene editing, biologicals, bio stimulants, and alternative fertilizers, and demonstrate the group's expertise in designing and executing M&A processes to achieve the best outcomes for its clients in a wide array of agriculture related sectors. ROTH MKM's Agribusiness Investment Banking Group served as the sellside advisor on the following transactions:

All MBII news

When does Marrone Bio Innovations report earnings?

Marrone Bio Innovations last reported on May 11, 2022, the date it announced on Apr 27, 2022. Before that it reported on Mar 28, 2022 and Nov 10, 2021.

MBII earnings history

Latest news

25 items

Marrone Bio Innovations Inc. (MBII) is a Major Chemicals company listed on NASDAQ. There were no new wire items for MBII in the last 30 days. The most recent was published Apr 11, 2023.

Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Davis, California.

MBII FAQ

7 questions
  • What does Marrone Bio Innovations Inc. do?
    Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial...
  • Where does MBII stock trade?
    Marrone Bio Innovations Inc. (MBII) is listed on NASDAQ.
  • What sector and industry is MBII in?
    Marrone Bio Innovations Inc. operates in the Basic Materials sector, Major Chemicals industry.
  • When did Marrone Bio Innovations Inc. go public?
    Marrone Bio Innovations Inc. (MBII) completed its IPO in 2013.
  • What are analysts saying about MBII?
    Marrone Bio Innovations Inc. has had 2 recent analyst actions on file. The most recent action was from Roth Capital: Buy with a $2.00 price target on 2021-09-22. Recent price targets range from $2.00 to $2.50.
  • What companies are similar to MBII?
    Notable peers in the same industry include APD (Air Products and Chemicals Inc.), LIN (Linde plc), IFF (International Flavors & Fragrances Inc.), DD (DuPont de Nemours Inc.), SOLS (Solstice Advanced Materials Inc.). Compare MBII side-by-side with any of them on Quantisnow.
  • How can I track MBII on Quantisnow?
    Quantisnow aggregates Marrone Bio Innovations Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MBII to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change